Document Detail

Anorexigenic effects of GLP-1 and its analogues.
MedLine Citation:
PMID:  22249815     Owner:  NLM     Status:  MEDLINE    
GLP-1 receptors are expressed in the brain, especially in the regions responsible for the regulation of food intake, and intracerebroventricular injection of GLP-1 results in inhibition of food intake. Peripheral administration of GLP-1 dose-dependently enhances satiety and reduces food intake in normal and obese subjects as well as in type 2 diabetic patients. So far, the mechanisms by which GLP-1 exerts its effects are not completely clear. Interactions with neurons in the gastrointestinal tract or possibly direct access to the brain through the blood-brain barrier as observed in rats are possible and discussed in this chapter as well as a novel hypothesis based on the finding that GLP-1 is also expressed in taste cells. Finally, the role of GLP-1 receptor agonists as a possible treatment option in obesity is discussed as well as the role of GLP-1 in the effects of bariatric surgery on adiposity and glucose homeostasis.
Baptist Gallwitz
Related Documents :
17799895 - Macroecology: the division of food and space among species on continents.
14756405 - Microanatomical and biological aspects of bacterial associations in tyrophagus putresce...
24374975 - The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics.
21265885 - The prevalence of food allergy in infants in chongqing, china.
3392605 - Effect of a formulation of supplementary food for pregnant women on birth weight of new...
24529075 - How well do modelled routes to school record the environments children are exposed to? ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Handbook of experimental pharmacology     Volume:  -     ISSN:  0171-2004     ISO Abbreviation:  Handb Exp Pharmacol     Publication Date:  2012  
Date Detail:
Created Date:  2012-01-17     Completed Date:  2012-04-25     Revised Date:  2013-03-19    
Medline Journal Info:
Nlm Unique ID:  7902231     Medline TA:  Handb Exp Pharmacol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  185-207     Citation Subset:  IM    
Medizinische Klinik IV, Otfried-Müller-Str. 10, 72076 Tübingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Appetite Depressants / pharmacology*
Appetite Regulation / drug effects
Bariatric Surgery
Body Weight / drug effects
Brain / drug effects*,  metabolism
Eating / drug effects
Glucagon-Like Peptide 1 / analogs & derivatives,  metabolism,  pharmacology*
Incretins / pharmacology*
Obesity / drug therapy,  metabolism,  surgery
Receptors, Glucagon / agonists*,  metabolism
Satiety Response / drug effects
Signal Transduction / drug effects
Reg. No./Substance:
0/Appetite Depressants; 0/Incretins; 0/Receptors, Glucagon; 0/glucagon-like peptide-1 receptor; 89750-14-1/Glucagon-Like Peptide 1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The role of ghrelin in the control of energy balance.
Next Document:  CCK, PYY and PP: The Control of Energy Balance.